MMR
Measles, Mumps, Rubella (MMR)
Indications
Two-dose live vaccine series; first dose ≥12 months in most programmes.
Doses
- Dose 1: 12 months
- Dose 2: Second dose per schedule (≥4 weeks after dose 1)
Contraindications
- Pregnancy
- Severe immunodeficiency
- Anaphylaxis to neomycin or gelatin (product-specific)
Precautions
- Recent blood products — delay per interval guidance
- Thrombocytopenia after prior MMR — specialist review
Sources
- • WHO Measles Position Paper (2017)